Eloxx Pharmaceuticals
Presencia
Eloxx Pharmaceuticals es una empresa que cotiza bajo el símbolo de cotización ELOX (US).
Ejecutivos
Ver el organigrama con sus 7 ejecutivos principales
Biografías más buscadas en Eloxx Pharmaceuticals
- Sumit Aggarwal, President, Chief Executive Officer
- Tomer Kariv, Chairman of the Board
- Alan Walts, Director
Crear su alerta
para seguir los movimientos de los ejecutivos en Eloxx Pharmaceuticals.
Farmacia
Eloxx Pharmaceuticals tiene 1.865 competidores entre los que se incluyen Pfizer (Estados Unidos), Sanofi (Francia) y Johnson & Johnson (Estados Unidos).
Popular M&A news in Farmacia
- AstraZeneca has announced the acquisition of Fusion Pharma (publicado el 23 de marzo de 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (publicado el 19 de marzo de 2024).
- Frontier Medicines acaba de anunciar una recaudación de fondos de 80 millones de dólares. (publicado el 27 de febrero de 2024).
Otros contactos sugeridos en el sector Farmacia
Noticias
Últimos comunicados de prensa de Eloxx Pharmaceuticals
- Eloxx Pharmaceuticals Announces Changes to Board of Directors | Eloxx Pharmaceuticals, Inc.
- Eloxx Pharmaceuticals Reports First Quarter 2022 Financial and Operating Results and Provides Business Update | Eloxx Pharmaceuticals, Inc.
- Eloxx Pharmaceuticals Announces Therapeutic Development Award from Cystic Fibrosis Foundation | Eloxx Pharmaceuticals, Inc.
- Eloxx Pharmaceuticals Reports Fourth Quarter 2021 Financial and Operating Results and Provides Business Update | Eloxx Pharmaceuticals, Inc.
- Eloxx Pharmaceuticals Announces New Development Program for ELX-02 for the Treatment of Alport Syndrome | Eloxx Pharmaceuticals, Inc.
- Eloxx Pharmaceuticals to Report Third Quarter 2020 Financial Results and Provide Business Update on November 5, 2020 | Eloxx Pharmaceuticals, Inc.
- Globally Renowned Cystic Fibrosis Expert, Dr. Eitan Kerem, Joins Eloxx Pharmaceuticals as a Senior Consultant | Eloxx Pharmaceuticals, Inc.
- Eloxx Announces Two Preclinical Abstracts Accepted for Presentation at the 2020 North American Cystic Fibrosis Virtual Conference in October | Eloxx Pharmaceuticals, Inc.
- Enrollment in the U.S. Phase 2 Clinical Trial in Cystic Fibrosis Has Resumed After Being Paused in Response to the COVID-19 Pandemic | Eloxx Pharmaceuticals, Inc.
- Eloxx Pharmaceuticals Reports Second Quarter 2020 Financial and Operating Results and Provides Business Update | Eloxx Pharmaceuticals, Inc.
- View more press releases Close
Redes sociales sobre Eloxx Pharmaceuticals
- Eloxx Pharmaceuticals en Wikipedia, Google News y Yahoo Finance
- Eloxx Pharmaceuticals en LinkedIn, Twitter y YouTube
Ponerse en contacto
Contactar a través de e-mail con sus ejecutivos Lindsay Androski 
Llame a Eloxx Pharmaceuticals al +1 781...
